AstraZeneca COVID-19 Antibody Could Be Solution For Vulnerable But Not Vaccine Alternative

Long-Acting Drug Filed With FDA

 
• By Andrew McConaghie
  
Astrazeneca
AstraZeneca's antibody therapy could be first to gain an EUA in 'pre-exposure prophylaxis'
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip